X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28239) 28239
Newsletter (386) 386
Newspaper Article (285) 285
Magazine Article (272) 272
Book Chapter (207) 207
Transcript (50) 50
Book / eBook (32) 32
Book Review (8) 8
Reference (7) 7
Web Resource (6) 6
Publication (4) 4
Streaming Video (4) 4
Trade Publication Article (4) 4
Dissertation (3) 3
Government Document (3) 3
Conference Proceeding (2) 2
Report (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (23072) 23072
male (12221) 12221
female (11731) 11731
middle aged (8448) 8448
adult (7443) 7443
aged (6668) 6668
gastroenterology & hepatology (5992) 5992
animals (4657) 4657
treatment outcome (4489) 4489
risk factors (3832) 3832
pharmacology & pharmacy (3699) 3699
gastrointestinal diseases (3421) 3421
oncology (3203) 3203
anti-inflammatory agents, non-steroidal - adverse effects (3172) 3172
care and treatment (3067) 3067
surgery (2974) 2974
medicine & public health (2946) 2946
gastrointestinal diseases - chemically induced (2627) 2627
cancer (2596) 2596
health aspects (2560) 2560
analysis (2523) 2523
gastrointestinal agents - therapeutic use (2421) 2421
aged, 80 and over (2332) 2332
research (2322) 2322
double-blind (2214) 2214
adolescent (2201) 2201
retrospective studies (2186) 2186
drug therapy (1885) 1885
therapy (1862) 1862
gastrointestinal agents - adverse effects (1791) 1791
medicine, general & internal (1786) 1786
nonsteroidal antiinflammatory drugs (1713) 1713
risk (1709) 1709
prospective studies (1691) 1691
gastrointestinal agents (1659) 1659
young adult (1649) 1649
gastroenterology (1622) 1622
gastrointestinal hemorrhage - chemically induced (1605) 1605
chemotherapy (1603) 1603
patients (1594) 1594
management (1557) 1557
time factors (1536) 1536
medical research (1507) 1507
gastroenterology and hepatology (1502) 1502
clinical trials (1487) 1487
abridged index medicus (1484) 1484
prevention (1481) 1481
double-blind method (1472) 1472
complications and side effects (1444) 1444
medicine (1431) 1431
child (1375) 1375
antineoplastic agents - adverse effects (1324) 1324
efficacy (1306) 1306
studies (1288) 1288
mortality (1274) 1274
dose-response relationship, drug (1239) 1239
inflammatory bowel disease (1226) 1226
inflammation (1214) 1214
internal medicine (1213) 1213
obesity (1210) 1210
anti-inflammatory agents, non-steroidal - therapeutic use (1205) 1205
mice (1203) 1203
endoscopy (1196) 1196
disease (1188) 1188
microbiota (1184) 1184
research article (1163) 1163
safety (1151) 1151
follow-up studies (1137) 1137
gastrointestinal surgery (1137) 1137
medicine, experimental (1136) 1136
rats (1133) 1133
diagnosis (1132) 1132
rheumatoid-arthritis (1127) 1127
gastrointestinal system (1116) 1116
intestine (1108) 1108
gastrointestinal hemorrhage - etiology (1091) 1091
gastrointestinal tract (1090) 1090
drug therapy, combination (1086) 1086
complications (1073) 1073
antineoplastic agents - therapeutic use (1069) 1069
drugs (1052) 1052
administration, oral (1010) 1010
inflammatory-bowel-disease (1006) 1006
infliximab (1004) 1004
usage (986) 986
review (983) 983
risk assessment (951) 951
pediatrics (940) 940
children (928) 928
immunology (919) 919
dosage and administration (915) 915
incidence (903) 903
tumors (899) 899
aspirin (887) 887
toxicity (883) 883
diarrhea (880) 880
aspirin - adverse effects (869) 869
prognosis (867) 867
multidisciplinary sciences (863) 863
randomized controlled trials as topic (863) 863
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28228) 28228
German (292) 292
French (275) 275
Spanish (227) 227
Japanese (213) 213
Russian (109) 109
Italian (80) 80
Chinese (41) 41
Dutch (34) 34
Hungarian (27) 27
Danish (25) 25
Korean (23) 23
Polish (21) 21
Swedish (20) 20
Czech (16) 16
Portuguese (15) 15
Norwegian (14) 14
Hebrew (12) 12
Croatian (6) 6
Serbian (5) 5
Ukrainian (5) 5
Finnish (4) 4
Romanian (4) 4
Arabic (2) 2
Lithuanian (2) 2
Turkish (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 2012, Volume 104, Issue 2, pp. 93 - 113
.... This has raised challenges in the management of adverse events (AEs) associated with the six targeted agents approved in RCC-sorafenib, sunitinib, pazopanib, bevacizumab... 
TYROSINE KINASE INHIBITORS | CONTROLLED-TRIAL | INTERFERON-ALPHA | SUNITINIB TREATMENT | CANCER-PATIENTS | VENOUS THROMBOEMBOLISM | ONCOLOGY | HEART-FAILURE | DOUBLE-BLIND | EXPANDED ACCESS PROGRAM | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Hypothyroidism - chemically induced | Pneumonia - therapy | Anorexia - therapy | Humans | Drug Eruptions - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Kidney Neoplasms - metabolism | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Weight Loss - drug effects | Benzenesulfonates - adverse effects | Bevacizumab | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Pyrroles - adverse effects | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Everolimus | Hypothyroidism - therapy | Wound Healing - drug effects | Molecular Targeted Therapy - methods | Sirolimus - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Sirolimus - analogs & derivatives | Europe | Gastrointestinal Tract - drug effects | Cardiovascular System - drug effects | Evidence-Based Medicine | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Anorexia - chemically induced | Kidney Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Carcinoma, Renal cell | Research | Drug therapy | Antineoplastic agents
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4782, 2009, Volume 6, Issue 8, pp. 465 - 477
.... with expanded clinical experience with this class of agents has come the increasing recognition of the diverse adverse effects related to disturbance of VEGF-dependent physiological functions... 
ONCOLOGY | POSTERIOR LEUKOENCEPHALOPATHY SYNDROME | TYROSINE KINASE INHIBITOR | PHASE-II | OVARIAN-CANCER | PACLITAXEL PLUS BEVACIZUMAB | THROMBOTIC MICROANGIOPATHY | METASTATIC COLORECTAL-CANCER | RENAL-CELL CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | COOPERATIVE-ONCOLOGY-GROUP | Humans | Antibodies, Monoclonal - therapeutic use | Neoplasm Proteins - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Benzenesulfonates - adverse effects | Bevacizumab | Brain Diseases - chemically induced | Benzenesulfonates - pharmacology | Pyridines - adverse effects | Drug Interactions | Kidney Diseases - chemically induced | Pyrroles - adverse effects | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal - pharmacology | Risk Factors | Angiogenesis Inhibitors - pharmacology | Forecasting | Indoles - adverse effects | Indoles - therapeutic use | Cardiovascular Diseases - chemically induced | Hemorrhage - chemically induced | Vascular Endothelial Growth Factor A - physiology | Niacinamide - analogs & derivatives | Receptors, Vascular Endothelial Growth Factor - physiology | Clinical Trials as Topic - statistics & numerical data | Neoplasm Proteins - physiology | Antibodies, Monoclonal - adverse effects | Cardiovascular Diseases - therapy | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Drug Delivery Systems | Antibodies, Monoclonal, Humanized | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Indoles - pharmacology | Antineoplastic Agents - pharmacology | Pyrroles - therapeutic use | Wound Healing - drug effects | Pyridines - therapeutic use | Hemorrhage - therapy | Pyrroles - pharmacology | Protein Kinase Inhibitors - therapeutic use | Capillary Leak Syndrome - chemically induced | Kidney Diseases - therapy | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Gastrointestinal Diseases - chemically induced | Antimitotic agents | Complications and side effects | Care and treatment | Colorectal cancer | Physiological aspects | Development and progression | Poisoning | Antineoplastic agents | Vascular endothelial growth factor | Risk factors | Tumors | Cancer | Index Medicus
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 2, pp. 380 - 388.e4
Journal Article
Burns, ISSN 0305-4179, 2014, Volume 41, Issue 4, pp. 658 - 679
...–iodine, chlorhexidine/alcohol (in preterm infants), laxatives, and vesicants (warfare agents), will be reviewed since these are the most common agents found in daily... 
Critical Care | Povidone–iodine | Vesicants | Inflation and rupture of airbags | Chemical burns | Nitric acid | Sulfuric acid | Chlorhexidine/alcohol | Hydrogen sulphide | Acetic acid and derivatives | Hydrofluoric acid | Paraquat | Laxatives | Calcium hydroxide (cement) | Hydrochloric acid (muriatic acid) | Sodium hydoxide (caustic soda) | Povidone-iodine | SURGERY | Povidone iodine | MUSTARD GAS | SULFUR-DIOXIDE INHALATION | DERMATOLOGY | CAUSTIC SODA INGESTION | CRITICAL CARE MEDICINE | WHITE PHOSPHORUS BURN | HYDROGEN-SULFIDE | HYDROFLUORIC-ACID BURNS | CEMENT BURNS | FULL-THICKNESS BURN | OF-THE-LITERATURE | POVIDONE-IODINE | Bone Cements - adverse effects | Calcium Hydroxide - adverse effects | Caustics - adverse effects | Hydrochloric Acid - adverse effects | Humans | Anti-Infective Agents, Local - adverse effects | Herbicides - adverse effects | Irritants - adverse effects | Hydrogen Sulfide - adverse effects | Laxatives - adverse effects | Acetic Acid - adverse effects | Burns, Chemical - etiology | Chemical Warfare Agents - adverse effects | Forensic Medicine | Povidone-Iodine - adverse effects | Sodium Hydroxide - adverse effects | Paraquat - adverse effects | Explosive Agents - adverse effects | Nitric Acid - adverse effects | Burns, Chemical - pathology | Acids - adverse effects | Air Pollutants - adverse effects | Air Bags - adverse effects | Chlorhexidine - adverse effects | Hydrogen sulfide | Herbicides | Hydroxides | Gastrointestinal agents | Hydrogen | Pharmacy | Emergency medicine | Forensic sciences | Burns, Chemical | Index Medicus
Journal Article
Drug safety, ISSN 0114-5916, 2000, Volume 23, Issue 5, pp. 429 - 448
... abnormalities.The newer 5-ASA agents were developed to deliver the active ingredient of sulfasalazine while minimising adverse effects... 
Mercaptopurine, general | Inflammatory bowel disease, treatment | Salicylates, general | Ciprofloxacin, general | Cyclosporin, general | Sulfasalazine, general | Azathioprine, general | Antibacterials, general | Metronidazole, general | Methotrexate, general | Tacrolimus, general | Immunomodulators, general | Mycophenolate mofetil, general | Aminosalicylic acid, general | Corticosteroids, general | RHEUMATOID-ARTHRITIS | LONG-TERM | RENAL-ALLOGRAFT RECIPIENTS | GLUCOCORTICOID-INDUCED OSTEOPOROSIS | ACTIVE CROHNS-DISEASE | RESISTANT ULCERATIVE-COLITIS | 5-AMINOSALICYLIC ACID | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | PLACEBO-CONTROLLED TRIAL | MYCOPHENOLATE-MOFETIL | Anti-Infective Agents - pharmacology | Humans | Immunosuppressive Agents - therapeutic use | Male | Sulfasalazine - pharmacology | Adrenal Cortex Hormones - therapeutic use | Prodrugs - metabolism | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Female | Immunosuppressive Agents - pharmacology | Inflammatory Bowel Diseases - drug therapy | Sulfasalazine - therapeutic use | Anti-Infective Agents - adverse effects | Mesalamine - adverse effects | Adrenal Cortex Hormones - pharmacology | Anti-Infective Agents - therapeutic use | Pregnancy | Adrenal Cortex Hormones - adverse effects | Gastrointestinal Agents - pharmacology | Mesalamine - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Gastrointestinal Agents - therapeutic use | Mesalamine - therapeutic use | Immunosuppressive Agents - adverse effects | Gastrointestinal Agents - adverse effects | Sulfasalazine - adverse effects
Journal Article
Gastroenterology (New York, N.Y. 1943), ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. 1078 - 1089
... (OR, 2.0; 95% CI, 1.6-2.5; P = 9.7 x 10.sup.-9). The association with A*33:01 was mediated by large effects for terbinafine-, fenofibrate-, and ticlopidine-related DILI... 
Gastroenterology and Hepatology | Side Effect | Medication | Liver Damage | Anti-Fungal Agent | POPULATION | SUSCEPTIBILITY | RISK | TERBINAFINE | TICLOPIDINE | HEPATITIS | CLASS-I | HEPATOTOXICITY | GASTROENTEROLOGY & HEPATOLOGY | T-CELLS | ANTIGEN | Antifungal Agents - adverse effects | Naphthalenes - adverse effects | Humans | Middle Aged | Male | Sertraline - adverse effects | Fenofibrate - adverse effects | Chromosomes, Human, Pair 2 - genetics | Ticlopidine - adverse effects | Female | Odds Ratio | Chemical and Drug Induced Liver Injury - etiology | Platelet Aggregation Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | European Continental Ancestry Group - genetics | Genetic Predisposition to Disease | Genome-Wide Association Study | Genes, MHC Class I - genetics | Chemical and Drug Induced Liver Injury - genetics | Terbinafine | Phenotype | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Alleles | HLA-A Antigens - genetics | Polymorphism, Single Nucleotide | Antidepressive Agents - adverse effects | Drugs | Medical research | Liver diseases | Liver | Genes | Genomics | Risk factors | Genetic polymorphisms | Analysis | Gastrointestinal diseases | Medicine, Experimental | Genetic research | Trade and professional associations | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | side effect | medication | anti-fungal agent | liver damage
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 8, pp. 1120 - 1129.e6
Journal Article
8.